Abstract:Background: Despite considerable research efforts, the precise etiology and underlying pathways contributing to Moyamoya Disease (MMD) remain poorly understood. Moreover, the overlapping vascular pathologies shared between MMD and Intracranial Atherosclerotic Disease (ICAD) pose challenges in clinical differentiation, even with gold-standard cerebral angiography. An in-depth exploration of lipidomic alterations in cerebral intracranial MMD vessels could offer valuable insights into the pathogenesis of MMD-related mechanisms, encompassing MMD and ICAD, and unveil novel biomarkers and potential therapeutic targets. However, to date, comprehensive lipidomic profiling has been lacking. Materials and methods: To discover novel biomarkers and unravel the pathophysiological mechanisms underlying MMD, we conducted a lipidomics analysis to characterize various lipid species in matched human extracranial and intracranial artery tissues from patients diagnosed with MMD (n=99) and ICAD (n=12). Results: Our analysis identified 569 lipid species and delineated a robust panel of lipidomic biomarkers capable of effectively distinguishing MMD from ICAD (area under curve=0.98), as determined by receiver operating characteristic curve analysis. Notably, we observed a significantly more pronounced positive correlation of diacylglycerols and a negative association of triglycerides in intracranial artery tissues of MMD patients compared to those with ICAD, suggesting a potential role of dysregulated diacylglycerol-induced signaling in MMD pathogenesis. Furthermore, our investigation into the correlations of critical differential intracranial artery vessel lipid species between MMD and ICAD and clinical parameters revealed negative associations with plasma iron levels, implying a potential link between plasma iron metabolism and artery lipid homeostasis during MMD pathogenesis. Conclusion: These findings offer promising prospects for advancing clinical diagnosis for enhanced differentiation between the two disease conditions. Additionally, they shed light on the fundamental mechanisms implicated in MMD pathogenesis and suggest potential therapeutic avenues through targeting artery vessel lipids or plasma iron levels.

Intracranial Aneurysms and Lipid Metabolism Disorders: From Molecular Mechanisms to Clinical Implications

[Autophagy Regulates the Function of Vascular Smooth Muscle Cells in the Formation and Rupture of Intracranial Aneurysms].

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis

Age-Related Impairment Of Vascular Structure And Functions

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Sphingolipids And Cardiovascular Diseases: Lipoprotein Metabolism, Atherosclerosis And Cardiomyopathy

Research Progress on the Pathogenesis of Aortic Aneurysm and Dissection in Metabolism

In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic disease

Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease

Inflammation, apoptosis and autophagy as critical players in vascular dementia

Study the local metabolic changes of aneurysms through microcatheter sampling

Pathological Changes in Microvascular Morphology, Density, Size and Responses Following Comorbid Cerebral Injury

Underlying mechanism of hemodynamics and intracranial aneurysm

[Molecular Mechanisms Underlying Intracranial Aneurysm Rupture]

Intracranial atherosclerotic disease and neurodegeneration: a narrative review and plausible mechanisms

Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease

Sphingolipid metabolism and atherosclerosis.

Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage